SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-021518
Filing Date
2021-04-14
Accepted
2021-04-14 16:01:19
Documents
2
Period of Report
2021-04-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea139486-8k_cmlifesciences2.htm 8-K 21773
2 PRESS RELEASE, DATED APRIL 13, 2021 ea139486ex99-1_cmlife2.htm EX-99.1 5575
  Complete submission text file 0001213900-21-021518.txt   28465
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences II Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40090 | Film No.: 21825700
SIC: 6770 Blank Checks